`J2351` Inj ocrelizumab 1mg hya-ocsq

Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 920 units per day (practitioner), rationale: Prescribing Information